Urinary MicroRNA Profiling in the Nephropathy of Type 1 Diabetes
Open Access
- 24 January 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (1) , e54662
Abstract
Patients with Type 1 Diabetes (T1D) are particularly vulnerable to development of Diabetic nephropathy (DN) leading to End Stage Renal Disease. Hence a better understanding of the factors affecting kidney disease progression in T1D is urgently needed. In recent years microRNAs have emerged as important post-transcriptional regulators of gene expression in many different health conditions. We hypothesized that urinary microRNA profile of patients will differ in the different stages of diabetic renal disease. We studied urine microRNA profiles with qPCR in 40 T1D with >20 year follow up 10 who never developed renal disease (N) matched against 10 patients who went on to develop overt nephropathy (DN), 10 patients with intermittent microalbuminuria (IMA) matched against 10 patients with persistent (PMA) microalbuminuria. A Bayesian procedure was used to normalize and convert raw signals to expression ratios. We applied formal statistical techniques to translate fold changes to profiles of microRNA targets which were then used to make inferences about biological pathways in the Gene Ontology and REACTOME structured vocabularies. A total of 27 microRNAs were found to be present at significantly different levels in different stages of untreated nephropathy. These microRNAs mapped to overlapping pathways pertaining to growth factor signaling and renal fibrosis known to be targeted in diabetic kidney disease. Urinary microRNA profiles differ across the different stages of diabetic nephropathy. Previous work using experimental, clinical chemistry or biopsy samples has demonstrated differential expression of many of these microRNAs in a variety of chronic renal conditions and diabetes. Combining expression ratios of microRNAs with formal inferences about their predicted mRNA targets and associated biological pathways may yield useful markers for early diagnosis and risk stratification of DN in T1D by inferring the alteration of renal molecular processes.Keywords
This publication has 64 references indexed in Scilit:
- A microRNA circuit mediates transforming growth factor-β1 autoregulation in renal glomerular mesangial cellsKidney International, 2011
- miR-21 and miR-214 Are Consistently Modulated during Renal Injury in Rodent ModelsThe American Journal of Pathology, 2011
- Mammalian microRNAs predominantly act to decrease target mRNA levelsNature, 2010
- The BUGS project: Evolution, critique and future directionsStatistics in Medicine, 2009
- Origins and Mechanisms of miRNAs and siRNAsCell, 2009
- Reactome knowledgebase of human biological pathways and processesNucleic Acids Research, 2008
- Most mammalian mRNAs are conserved targets of microRNAsGenome Research, 2008
- Real-time PCR quantification of precursor and mature microRNAMethods, 2008
- MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-β-induced collagen expression via inhibition of E-box repressorsProceedings of the National Academy of Sciences, 2007
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001